|
|
Volumn 172, Issue 3, 2015, Pages 819-821
|
|
Dramatic efficacy of brentuximab vedotin in two patients with epidermotropic cutaneous T-cell lymphomas after treatment failure despite variable CD30 expression
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
BEXAROTENE;
BRENTUXIMAB VEDOTIN;
CARMUSTINE;
CD30 ANTIGEN;
CHLORMETHINE;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ETRETIN;
PREDNISONE;
VINCRISTINE;
VORINOSTAT;
ANTIBODY CONJUGATE;
ANTINEOPLASTIC AGENT;
CAC10-VCMMAE;
ADULT;
AGED;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER REGRESSION;
CASE REPORT;
CUTANEOUS T CELL LYMPHOMA;
DRUG EFFICACY;
DRUG INFUSION;
DRUG SAFETY;
DRUG TREATMENT FAILURE;
ERYSIPELAS;
HUMAN;
LETTER;
MALE;
MIDDLE AGED;
MULTIPLE CYCLE TREATMENT;
MYCOSIS FUNGOIDES;
PHOTOCHEMOTHERAPY;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SENSORIMOTOR NEUROPATHY;
SEZARY SYNDROME;
DISEASE COURSE;
LYMPHOMA, T-CELL, CUTANEOUS;
METABOLISM;
SKIN NEOPLASMS;
TREATMENT OUTCOME;
AGED;
ANTIGENS, CD30;
ANTINEOPLASTIC AGENTS;
DISEASE PROGRESSION;
HUMANS;
IMMUNOCONJUGATES;
LYMPHOMA, T-CELL, CUTANEOUS;
MALE;
MIDDLE AGED;
SEZARY SYNDROME;
SKIN NEOPLASMS;
TREATMENT OUTCOME;
|
|
EID: 84925263351
PISSN: 00070963
EISSN: 13652133
Source Type: Journal
DOI: 10.1111/bjd.13337 Document Type: Letter |
|
Times cited : (13)
|
|
References (6)
|
